Cargando…
Pyoverdine Inhibitors and Gallium Nitrate Synergistically Affect Pseudomonas aeruginosa
Pseudomonas aeruginosa is a multidrug-resistant, opportunistic pathogen that frequently causes ventilator-associated pneumonia in intensive care units and chronic lung infections in cystic fibrosis patients. The rising prevalence of drug-resistant bacteria demands the exploration of new therapeutic...
Autores principales: | Kang, Donghoon, Revtovich, Alexey V., Deyanov, Alexander E., Kirienko, Natalia V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265654/ https://www.ncbi.nlm.nih.gov/pubmed/34133200 http://dx.doi.org/10.1128/mSphere.00401-21 |
Ejemplares similares
-
Novel Pyoverdine Inhibitors Mitigate Pseudomonas aeruginosa Pathogenesis
por: Kirienko, Daniel R., et al.
Publicado: (2019) -
A High-Content, Phenotypic Screen Identifies Fluorouridine as an Inhibitor of Pyoverdine Biosynthesis and Pseudomonas aeruginosa Virulence
por: Kirienko, Daniel R., et al.
Publicado: (2016) -
Pyoverdine-Dependent Virulence of Pseudomonas aeruginosa Isolates From Cystic Fibrosis Patients
por: Kang, Donghoon, et al.
Publicado: (2019) -
Identification and validation of a novel anti-virulent that binds to pyoverdine and inhibits its function
por: Wang, Xu, et al.
Publicado: (2020) -
High-Throughput Genetic Screen Reveals that Early Attachment and Biofilm Formation Are Necessary for Full Pyoverdine Production by Pseudomonas aeruginosa
por: Kang, Donghoon, et al.
Publicado: (2017)